ATP7A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.072000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.712400E-01
Normal-vs-Stage2
8.326000E-01
Normal-vs-Stage3
2.374300E-02
Normal-vs-Stage4
2.866600E-01
Stage1-vs-Stage2
9.729800E-01
Stage1-vs-Stage3
1.732420E-02
Stage1-vs-Stage4
1.003180E-01
Stage2-vs-Stage3
1.316140E-03
Stage2-vs-Stage4
8.569800E-02
Stage3-vs-Stage4
4.447800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.639200E-01
Normal-vs-AfricanAmerican
6.662400E-01
Normal-vs-Asian
6.623400E-01
Caucasian-vs-AfricanAmerican
2.732400E-01
Caucasian-vs-Asian
7.395200E-01
AfricanAmerican-vs-Asian
2.910800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.355400E-01
Normal-vs-Female
7.864000E-01
Male-vs-Female
8.545000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.135800E-01
Normal-vs-Age(41-60Yrs)
7.891600E-01
Normal-vs-Age(61-80Yrs)
6.581000E-01
Normal-vs-Age(81-100Yrs)
2.909000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.411400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.048600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.084000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.283850E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.372100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.686200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.096400E-01
Normal-vs-Daily Drinker
4.119000E-01
Normal-vs-Weekly Drinker
7.528000E-01
Normal-vs-Occasional Drinker
7.277200E-01
Normal-vs-Social Drinker
9.285000E-01
Non Drinker-vs-Daily Drinker
4.906800E-01
Non Drinker-vs-Weekly Drinker
8.590400E-01
Non Drinker-vs-Occasional Drinker
5.597600E-02
Non Drinker-vs-Social Drinker
4.926000E-01
Daily Drinker-vs-Weekly Drinker
5.305000E-01
Daily Drinker-vs-Occasional Drinker
3.735900E-02
Daily Drinker-vs-Social Drinker
2.594000E-01
Weekly Drinker-vs-Occasional Drinker
2.650600E-01
Weekly Drinker-vs-Social Drinker
7.052800E-01
Occasional Drinker-vs-Social Drinker
4.584800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.561970E-01
Normal-vs-Grade 2
4.489600E-02
Normal-vs-Grade 3
1.020980E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.284800E-01
Grade 1-vs-Grade 3
1.725450E-01
Grade 1-vs-Grade 4
1.561970E-01
Grade 2-vs-Grade 3
2.737200E-01
Grade 2-vs-Grade 4
4.489600E-02
Grade 3-vs-Grade 4
1.020980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.950800E-01
Normal-vs-NonDiabetic
7.288600E-01
Diabetic-vs-NonDiabetic
7.777400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.006400E-01
Normal-vs-NoPancreatitis
7.719800E-01
Pancreatitis-vs-NoPancreatitis
3.936800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.533000E-01
Normal-vs-N1
8.478400E-01
N0-vs-N1
6.642200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.615800E-01
Normal-vs-TP53-NonMutant
8.610600E-01
TP53-Mutant-vs-TP53-NonMutant
6.725200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
